Neutraliserende antistoffer er forbundet med en reduktion af de biologiske virkninger af AVONEX in vivo, og kan medføre en reduktion af klinisk effekt.
Neutralising antibodies are associated with a reduction in the in vivo biological effects of AVONEX and may potentially be associated with a reduction of clinical efficacy.